genprowebdirectory
GEN Edge
News
Insights
Trends for 2021
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Cancer
The Life Oncolytic, with Stephen Russell
Synthetic Biology
Flush with Cash, Foresite Aims to Live Up to Its Name
OMICs
From Genomes to Drugs: An Interview with Vertex CSO David Altshuler
Gene Therapy
AI Gets Gene Therapy Over the Immunity Hump
Coronavirus
Immunai Expands from Observational to Functional Genomics
News
News
Light-Controlled Clustering of Receptors Acts Like a Signal to Trigger Cellular…
Coronavirus
Five COVID-19 Projects at UCSD Receive $33 million from NIH
OMICs
Scientists Sequence 64 Human Genomes as New Reference for Genetic Diversity
OMICs
Changes in the Gut Microbiome Potentially Linked to Alzheimer’s
Translational Medicine
Third Protein Found That Helps Regulate Development of Stem Cells into…
Insights
All
Trends for 2021
Trends for 2020
A-Lists
Top 7 Best Selling COVID-19 Vaccines and Drugs of 2020
Bioprocessing
COVID-19 Increasing Risk of Cyberattacks for Digital Biopharma
Bioprocessing
Case Study: How to Accelerate COVID-19 Vaccine Development
Bioprocessing
Flexibility is Key to Advances in Biomanufacturing
A-Lists
A-Lists
Top 7 Best Selling COVID-19 Vaccines and Drugs of 2020
January 2021 Vol. 41 No. 1
Seven Biopharma Trends to Watch in 2021
A-Lists
Top 15 Best-Selling Drugs Launched in 2020
A-Lists
Top 50 NIH-Funded Institutions of 2020
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
OMICs
Scientists Sequence 64 Human Genomes as New Reference for Genetic Diversity
OMICs
Changes in the Gut Microbiome Potentially Linked to Alzheimer’s
Translational Medicine
Third Protein Found That Helps Regulate Development of Stem Cells into…
Coronavirus
FDA Authorizes Emergency Use of J&J’s Single-Shot COVID-19 Vaccine
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Blood Disorders
Blood Disorders
Most popular
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Blood Disorders
Sanofi Snaps Up Bioverativ for $11.6B, Boosting Hemophilia and Rare Disease Offerings
Blood Disorders
Oxford BioMedica, Bioverativ to Develop Lentiviral Vectors for Hemophilia Gene Therapy
Blood Disorders
Biogen Idec Takes Over Development of Hemophilia Therapies in Deal with Swedish Orphan Biovitrum
Blood Disorders
GSK Reports Japanese Clearance for ITP Drug as Partner Ligand Gets $2M in Govt Grants
Blood Disorders
FDA Imposes Clinical Hold on Bellicum Lead Candidate BPX-501
Blood Disorders
CRISPR “One Shot” Cell Therapy for Hemophilia Developed
Blood Disorders
Artificial Bone Marrow Supports Blood Stem Cells for Disease Modelling and...
Blood Disorders
Leukemia Cells Take the Fast Track to the Nervous System
Blood Disorders
Lentigen and Expression Therapeutics to Develop Hemophilia A Therapies
Blood Disorders
PhaseBio Inks License to Develop MedImmune’s Reversal Agent for Blood Thinner
Blood Disorders
Pfizer, Sangamo Report Positive Phase I/II Data for Severe Hemophilia A...
Blood Disorders
Intrinsic LifeSciences Wins $4.45M Grant to Test Anemia Dx
Blood Disorders
Spark Therapeutics Stock Tumbles after Mixed Results from Phase I/II Trial...
Blood Disorders
Peptide Nucleic Acids Used to Edit Genes, Cure Mice of Inherited...
Blood Disorders
Senescent Cells Promote Blood Clotting
1
2
3
...
7
Page 1 of 7
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
![Leukemia Blood Cell [Kateryna Kon/Science Photo Library/Getty Images]](https://www.genengnews.com/wp-content/uploads/2018/08/Jul18_2018_Getty_685029693_LeukemiaBloodCell_6001216814959-324x160.jpg "Leukemia Cells Take the Fast Track to the Nervous System")
![Spark Therapeutics saw its share price tumble about 30% in early-morning trading after it reported mixed preliminary data this morning from a Phase I/II trial of its hemophilia A gene therapy candidate SPK-8001. [Source: wildpixel/Getty Images]](https://www.genengnews.com/wp-content/uploads/2018/08/Dec7_2017_Getty_487489316_GeneTherapy_60019871441892139879144-324x160.jpg "Spark Therapeutics Stock Tumbles after Mixed Results from Phase I/II Trial of Hemophilia A Candidate")
